In March, the Western District of the Hongqi Pharmaceutical Government Procurement Affairs Department ushered in the first government bidding project in 2019-the Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention of anti-tuberculosis drug bidding. This bidding project will carry out the government bidding of Hongqi Pharmaceutical's first consistency evaluation product-pyrazinamide tablets, which is very important to Hongqi Pharmaceutical and is also a milestone.

On March 11, under the on-site command of the company’s leaders and the on-site command of Manager Wei Dong, the director of the Western District of the Government Procurement Department, the Western District team made preparations for the bidding for the second day overnight. On March 12, after three hours of bid evaluation, the bidding work was successfully completed. The smooth completion of this consistency evaluation variety in the Xinjiang government bidding indicates that the Hongqi Pharmaceutical Government Procurement Workstation has reached a new starting point and achieved a new leap.

Hongqi Pharmaceutical's first product to pass the consistency evaluation-pyrazinamide tablets, took the lead in winning the bid in a government procurement project and won unanimous praise from field experts, fully demonstrating the brand power and product strength of Hongqi Pharmaceutical. West District Director Wei Dong expressed his gratitude to the expert group for the recognition and support on behalf of the company, and said that Hongqi Pharmaceuticals will insist on making good products, providing quality services, and ensuring the supply of drugs for the country's fight against tuberculosis.

The experts at the scene affirmed the achievements of Hongqi Pharmaceuticals and thanked Hongqi Pharmaceuticals for fighting side by side with frontline medical workers against tuberculosis for more than 30 years. At the same time, the experts also put forward higher expectations for Hongqi Pharmaceuticals and hope Hongqi Pharmaceuticals will soon. Realize second-line drugs and multi-dose product services.

The success of the first battle in the Western Region of the Government Procurement Department of Hongqi Pharmaceutical in 2019 has greatly encouraged the team in the Western Region and is more confident to rely on the corporate platform to better serve the prevention and control of tuberculosis in western China and provide more, better and more timely products. service.